The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision,Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals. Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event. Agenda Overview: Day 1 Morning:The integration and challenges of regulatory science and the patent systemü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systemsü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination Systemü Patent Challenges in the ADC/Bispecific Antibody 2.0 Eraü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage SystemsDay 1 Afternoon:Maximizing Patent Value and New Commercialization Modelsü Biosimilar Patent Challenge Strategies and Patent Cliff Managementü Patent Due Diligence and Investment Risksü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigationü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy ComplianceDay 2 Morning:Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competitionü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countriesü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaborationü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companiesü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual PropertyDay 2 Afternoon:Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Propertyü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapyü Patent Eligibility and Data Protection in AI-Driven Drug Developmentü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage Systemü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies More details about the topics, please find attached agenda. Partial inviting Companies & Institutions : CNIPAEUIPOWIPOPhIRDAEli Lilly and CompanyNovo NordiskJohnson & JohnsonAbbVieMerck Sharp & DohmeRocheAstraZenecaNovartisPfizerAmgenSanofiGileadSciencesBristol-Myers SquibbVertex PharmaceuticalsRegeneron PharmaceuticalsNovo NordiskChugai PharmaceuticalGSKMerck KGaASun PharmaceuticalCVS HealthDaiichi SankyōLONZATakeda PharmaceuticalHengrui PharmaceuticalsUCBArgenxAlnylam Pharmaceuticals IncCelltrionOtsuka HoldingsGalderma GroupTEVAWuXi AppTecWest PharmaceuticalBeiGeneBiogen IncLabCorpBayerDivis LaboratoriesSandozICONAstellas PharmaModernaBaxterNeurocrine BiosciencesCipla Ltd.,ViatrisHansoh PharmDr. Reddy'sLupin LimitedServierIncyte, CorpGenmabEisaiLuoxin Pharmaceutical GroupCSPC PharmaTide PharmaceuticalBRILLIANT PHARMACEUTICALInnovent BiologicsBio-Thera SolutionsSalubris PharmaceuticalsHaiscom pharmaceuticalEaston BiopharmaceuticalsHua MedicineGenscript CorporationTransThera BiosciencesCHIPSCREEN BIOSCIENCESHumanwell PharmaceuticalFosun Kite BiotechnologyHybio PharmaceuticalAllist PharmaceuticalsXiangxue Life SciencesHumanwell HealthcareXuanZhu PharmaStaidsonShineway PharmaceuticalKanghong PharmaceuticalI-Mab BiopharmaCRDCNew Era PharmaceuticalAscentage PharmaARSUAMOONJiangxi Jemincare GroupYangzijiang PharmaceuticalLintonPharm Co., Ltd.Grand PharmaceuticalQilu PharmaceuticalShanghai PharmaceuticalsKelun PharmaceuticalBuchang PharmaceuticalsLivzon PharmaceuticalSunshineLakeHuahai PharmaceuticalConba Pharmaceutical3SBio Inc.Jiuzhou PharmaceuticalHisun PharmaceuticalSimcere PharmaceuticalBeijing Intellectual Property CourtShanghai Technology ExchangeNhwa Pharmaceutical Tongyuankang PharmaceuticalKangma BiotechnologyRege BiotechZhejiang BaiChengPharmaceuticalTongji UniversityHitGen Inc.Impact TherapeuticsHutchison China MediTechCR Double CraneSinocelltech Gendicine BiopharmaceuticalShenyang Xingqi PharmaceuticalImpact TherapeuticsAsieris PharmaceuticalsMetseraLaNova MedicinesInnolake BiopharmChengdu Guowei BiologicalRibo Life Science Johnson & Johnson MedTechAdlai NortyeKejun PharmaceuticalBeijing Wuhe Boao PharmaceuticalYoujia (Hangzhou) BiotechnologyLyvgen BiopharmaMabwell (Shanghai) BioscienceIASO BioTOT BiopharmSuzhou Gelanke PharmaceuticalBioNTechSanegeneBioMedical Academy of Sciences & ResearchKangbaida (Sichuan) BiologicalShanghai Luoqi BiotechnologyYuekang Kechuang PharmaceuticalSunshineLakeKelun-Bota BiotechChina Biologic ProductsJunhemeng BiotechXiamen Amoytop BiotechYuansong BiotechnologyWuXi BiologicsJ Xinnian PharmaceuticalShanghai Yunsheng Yanxin BiotechSimcere Pharmaceuticalwebsite://en.zvuaz.cn/p/1176775/
引(yin)言(yan)(yan)隨(sui)(sui)(sui)(sui)著(zhu)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)產(chan)業(ye)(ye)(ye)(ye)向(xiang)(xiang)“新(xin)四化(hua)(hua)(hua)”(電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)化(hua)(hua)(hua)、智(zhi)能(neng)化(hua)(hua)(hua)、網聯(lian)化(hua)(hua)(hua)、共享(xiang)化(hua)(hua)(hua))深(shen)度轉型,其(qi)(qi)(qi)(qi)(qi)(qi)競爭核心(xin)已從(cong)傳(chuan)(chuan)統(tong)(tong)(tong)的(de)(de)(de)(de)(de)(de)(de)(de)機械制(zhi)(zhi)(zhi)造(zao)轉變為(wei)(wei)(wei)芯片(pian)、軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)、電(dian)(dian)(dian)池(chi)(chi)技(ji)(ji)術(shu)(shu)(shu)和(he)(he)(he)(he)智(zhi)能(neng)算(suan)法(fa)的(de)(de)(de)(de)(de)(de)(de)(de)比拼。這(zhe)(zhe)使得知(zhi)(zhi)識(shi)產(chan)權(quan)(quan)(quan)(quan)(quan)(IP)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)*關(guan)(guan)鍵(jian)(jian)的(de)(de)(de)(de)(de)(de)(de)(de)資(zi)(zi)產(chan)和(he)(he)(he)(he)護(hu)城河,同時(shi)(shi)也引(yin)發(fa)(fa)了(le)(le)(le)全(quan)球范(fan)圍(wei)內(nei)(nei)(nei)日(ri)益頻繁且復雜(za)的(de)(de)(de)(de)(de)(de)(de)(de)知(zhi)(zhi)識(shi)產(chan)權(quan)(quan)(quan)(quan)(quan)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。本案(an)(an)(an)(an)(an)(an)(an)例(li)集(ji)收(shou)錄(lu)了(le)(le)(le)2020年(nian)(nian)(nian)(nian)(nian)至(zhi)2025年(nian)(nian)(nian)(nian)(nian)間(jian)具有代(dai)表(biao)性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)全(quan)球汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)。一、 電(dian)(dian)(dian)池(chi)(chi)技(ji)(ji)術(shu)(shu)(shu)與(yu)(yu)(yu)電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)核心(xin)**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)1:LG化(hua)(hua)(hua)學(xue)(xue) vs. SK創(chuang)新(xin) (2020-2021年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)-2021年(nian)(nian)(nian)(nian)(nian)爭議(yi)(yi)領域(yu)(yu): 電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)池(chi)(chi)技(ji)(ji)術(shu)(shu)(shu)(商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi))案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 韓國(guo)(guo)(guo)兩大(da)(da)電(dian)(dian)(dian)池(chi)(chi)巨頭在(zai)美(mei)國(guo)(guo)(guo)爆發(fa)(fa)激烈法(fa)律戰(zhan)。LG化(hua)(hua)(hua)學(xue)(xue)(現為(wei)(wei)(wei)LG能(neng)源(yuan)(yuan)(yuan)解(jie)(jie)決(jue)(jue)(jue)方(fang)案(an)(an)(an)(an)(an)(an)(an))指(zhi)(zhi)(zhi)控(kong)SK創(chuang)新(xin)(SK Innovation)通(tong)過(guo)雇(gu)傭其(qi)(qi)(qi)(qi)(qi)(qi)前(qian)員工(gong)竊(qie)取(qu)了(le)(le)(le)大(da)(da)量(liang)與(yu)(yu)(yu)電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)池(chi)(chi)技(ji)(ji)術(shu)(shu)(shu)相(xiang)關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi),包括(kuo)關(guan)(guan)于(yu)鋰電(dian)(dian)(dian)池(chi)(chi)隔膜的(de)(de)(de)(de)(de)(de)(de)(de)關(guan)(guan)鍵(jian)(jian)技(ji)(ji)術(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 美(mei)國(guo)(guo)(guo)國(guo)(guo)(guo)際(ji)貿(mao)易(yi)委員會(hui)(ITC)于(yu)2021年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)作出*終(zhong)裁決(jue)(jue)(jue),對(dui)SK創(chuang)新(xin)發(fa)(fa)出為(wei)(wei)(wei)期10年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)禁止(zhi)(zhi)令,禁止(zhi)(zhi)其(qi)(qi)(qi)(qi)(qi)(qi)向(xiang)(xiang)美(mei)國(guo)(guo)(guo)進(jin)口電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)池(chi)(chi)、模(mo)塊(kuai)、電(dian)(dian)(dian)池(chi)(chi)包及相(xiang)關(guan)(guan)零部(bu)(bu)件(jian)(jian)(jian)(jian)。*終(zhong),在(zai)拜登政(zheng)府(fu)介入和(he)(he)(he)(he)雙方(fang)壓(ya)力下,2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue),雙方(fang)達(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。SK創(chuang)新(xin)向(xiang)(xiang)LG支付(fu)2萬(wan)(wan)(wan)億韓元(yuan)(yuan)(約(yue)18億美(mei)元(yuan)(yuan))的(de)(de)(de)(de)(de)(de)(de)(de)賠(pei)(pei)償(chang)金(jin)(包括(kuo)現金(jin)和(he)(he)(he)(he)版稅),并(bing)撤回相(xiang)關(guan)(guan)訴(su)訟。來(lai)源(yuan)(yuan)(yuan):United States International Trade Commission. (2021). Certain Lithium Ion Batteries, Battery Cells, Battery Modules, Battery Packs, Components Thereof, and Processes Therefor. Investigation No. 337-TA-1159.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)11日(ri)). LG Energy, SK Innovation reach settlement in battery dispute.案(an)(an)(an)(an)(an)(an)(an)例(li)2:寧德時(shi)(shi)代(dai) vs. 中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang) (2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)間(jian): 2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)爭議(yi)(yi)領域(yu)(yu): 鋰電(dian)(dian)(dian)池(chi)(chi)結(jie)(jie)構技(ji)(ji)術(shu)(shu)(shu)**(正(zheng)(zheng)(zheng)極(ji)極(ji)片(pian)、防爆閥等(deng)(deng)(deng))案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)動(dong)(dong)(dong)(dong)(dong)力電(dian)(dian)(dian)池(chi)(chi)巨頭寧德時(shi)(shi)代(dai)(CATL)對(dui)其(qi)(qi)(qi)(qi)(qi)(qi)競爭對(dui)手中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang)(CALB)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi)多(duo)項**侵(qin)(qin)(qin)(qin)權(quan)(quan)(quan)(quan)(quan)訴(su)訟,指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)(qi)侵(qin)(qin)(qin)(qin)犯(fan)了(le)(le)(le)包括(kuo)“正(zheng)(zheng)(zheng)極(ji)極(ji)片(pian)及電(dian)(dian)(dian)池(chi)(chi)”、“防爆裝置”在(zai)內(nei)(nei)(nei)的(de)(de)(de)(de)(de)(de)(de)(de)多(duo)項核心(xin)**。此案(an)(an)(an)(an)(an)(an)(an)被(bei)視為(wei)(wei)(wei)中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)電(dian)(dian)(dian)池(chi)(chi)行(xing)(xing)業(ye)(ye)(ye)(ye)史上(shang)*大(da)(da)規模(mo)的(de)(de)(de)(de)(de)(de)(de)(de)**戰(zhan)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 經(jing)(jing)(jing)過(guo)多(duo)輪庭(ting)審(shen),2023年(nian)(nian)(nian)(nian)(nian),福建(jian)省高級人(ren)民(min)(min)法(fa)院(yuan)作出終(zhong)審(shen)判(pan)決(jue)(jue)(jue),裁定中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang)侵(qin)(qin)(qin)(qin)犯(fan)寧德時(shi)(shi)代(dai)兩項**,需(xu)立即停止(zhi)(zhi)銷(xiao)售侵(qin)(qin)(qin)(qin)權(quan)(quan)(quan)(quan)(quan)產(chan)品,并(bing)賠(pei)(pei)償(chang)寧德時(shi)(shi)代(dai)總計(ji)(ji)(ji)約(yue)人(ren)民(min)(min)幣5700萬(wan)(wan)(wan)元(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)經(jing)(jing)(jing)濟損(sun)失。此外(wai),中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang)還被(bei)要(yao)求支付(fu)高達(da)數(shu)百萬(wan)(wan)(wan)元(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)**許(xu)可(ke)費。來(lai)源(yuan)(yuan)(yuan):福建(jian)省高級人(ren)民(min)(min)法(fa)院(yuan) (2023) 閩民(min)(min)終(zhong)XX號民(min)(min)事判(pan)決(jue)(jue)(jue)書(具體(ti)案(an)(an)(an)(an)(an)(an)(an)號因公開(kai)信(xin)息省略(lve))。第一財(cai)經(jing)(jing)(jing). (2023年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)21日(ri)). 《寧德時(shi)(shi)代(dai)與(yu)(yu)(yu)中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang)**戰(zhan)落(luo)幕(mu):中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)新(xin)航(hang)(hang)賠(pei)(pei)償(chang)5700萬(wan)(wan)(wan)元(yuan)(yuan)》。二(er)、 自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛與(yu)(yu)(yu)智(zhi)能(neng)網聯(lian)技(ji)(ji)術(shu)(shu)(shu)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)3:Waymo vs. Uber (2020年(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie)(jie)后(hou)(hou)延續(xu)影響(xiang)(xiang))時(shi)(shi)間(jian): 2017年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi),2020年(nian)(nian)(nian)(nian)(nian)達(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)但(dan)影響(xiang)(xiang)持(chi)續(xu)。爭議(yi)(yi)領域(yu)(yu): 激光(guang)雷(lei)達(da)(LiDAR)和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi)案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 谷歌(ge)旗下自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛公司(si)(si)Waymo指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)(qi)前(qian)工(gong)程(cheng)(cheng)師(shi)Anthony Levandowski在(zai)離職前(qian)下載(zai)了(le)(le)(le)超過(guo)1.4萬(wan)(wan)(wan)份機密(mi)(mi)文件(jian)(jian)(jian)(jian),并(bing)隨(sui)(sui)(sui)(sui)后(hou)(hou)創(chuang)辦了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛卡(ka)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)公司(si)(si)Otto(后(hou)(hou)被(bei)Uber收(shou)購(gou)),Uber因此使用(yong)了(le)(le)(le)這(zhe)(zhe)些(xie)(xie)技(ji)(ji)術(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 雙方(fang)于(yu)2018年(nian)(nian)(nian)(nian)(nian)達(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie),但(dan)2020年(nian)(nian)(nian)(nian)(nian),該案(an)(an)(an)(an)(an)(an)(an)有了(le)(le)(le)后(hou)(hou)續(xu)進(jin)展(zhan)(zhan)(zhan)。Anthony Levandowski因盜竊(qie)商(shang)(shang)業(ye)(ye)(ye)(ye)機密(mi)(mi)被(bei)美(mei)國(guo)(guo)(guo)法(fa)院(yuan)判(pan)處18個月(yue)(yue)(yue)監禁(后(hou)(hou)獲(huo)特(te)朗(lang)普特(te)赦)。此案(an)(an)(an)(an)(an)(an)(an)確(que)立了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛領域(yu)(yu)商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi)保護(hu)的(de)(de)(de)(de)(de)(de)(de)(de)極(ji)端重要(yao)性(xing),為(wei)(wei)(wei)后(hou)(hou)續(xu)類似案(an)(an)(an)(an)(an)(an)(an)件(jian)(jian)(jian)(jian)提供了(le)(le)(le)判(pan)例(li)。來(lai)源(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:17-cv-00939-WHA.The New York Times. (2020年(nian)(nian)(nian)(nian)(nian)8月(yue)(yue)(yue)5日(ri)). Ex-Google Engineer Avoids Prison After Trump Commutes Sentence.案(an)(an)(an)(an)(an)(an)(an)例(li)4:特(te)斯拉(la) vs. 小(xiao)(xiao)鵬汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che) (2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi),2021年(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie)(jie))時(shi)(shi)間(jian): 2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi)訴(su)訟,2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。爭議(yi)(yi)領域(yu)(yu): 自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛源(yuan)(yuan)(yuan)代(dai)碼(ma)(ma)與(yu)(yu)(yu)商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi)案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 特(te)斯拉(la)起(qi)(qi)(qi)(qi)(qi)(qi)訴(su)其(qi)(qi)(qi)(qi)(qi)(qi)前(qian)華裔工(gong)程(cheng)(cheng)師(shi)曹光(guang)植,指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)(qi)在(zai)入職小(xiao)(xiao)鵬汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)前(qian),將(jiang)特(te)斯拉(la)自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛系統(tong)(tong)(tong)Autopilot的(de)(de)(de)(de)(de)(de)(de)(de)源(yuan)(yuan)(yuan)代(dai)碼(ma)(ma)副(fu)本上(shang)傳(chuan)(chuan)至(zhi)其(qi)(qi)(qi)(qi)(qi)(qi)個人(ren)iCloud賬戶。小(xiao)(xiao)鵬汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)作為(wei)(wei)(wei)曹光(guang)植的(de)(de)(de)(de)(de)(de)(de)(de)新(xin)雇(gu)主(zhu)被(bei)卷(juan)入訴(su)訟。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 經(jing)(jing)(jing)過(guo)長達(da)兩年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)調查和(he)(he)(he)(he)庭(ting)審(shen),雙方(fang)于(yu)2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。特(te)斯拉(la)對(dui)小(xiao)(xiao)鵬汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)的(de)(de)(de)(de)(de)(de)(de)(de)技(ji)(ji)術(shu)(shu)(shu)共享(xiang)請(qing)(qing)求表(biao)示滿意,并(bing)結(jie)(jie)束(shu)了(le)(le)(le)此案(an)(an)(an)(an)(an)(an)(an)。此案(an)(an)(an)(an)(an)(an)(an)凸顯了(le)(le)(le)中(zhong)(zhong)(zhong)(zhong)(zhong)美(mei)科(ke)技(ji)(ji)公司(si)(si)在(zai)尖(jian)端技(ji)(ji)術(shu)(shu)(shu)人(ren)才競爭中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)IP沖(chong)突。來(lai)源(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:19-cv-01463-RS.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)16日(ri)). Tesla settles lawsuit against engineer who moved to Xpeng Motors.(預(yu)(yu)測) 案(an)(an)(an)(an)(an)(an)(an)例(li)5:某(mou)科(ke)技(ji)(ji)公司(si)(si) vs. 某(mou)傳(chuan)(chuan)統(tong)(tong)(tong)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi) (2025年(nian)(nian)(nian)(nian)(nian)預(yu)(yu)測)時(shi)(shi)間(jian): 2025年(nian)(nian)(nian)(nian)(nian)(預(yu)(yu)測)爭議(yi)(yi)領域(yu)(yu): 大(da)(da)模(mo)型在(zai)智(zhi)能(neng)座(zuo)艙中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)應用(yong)**案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 隨(sui)(sui)(sui)(sui)著(zhu)生成(cheng)(cheng)(cheng)(cheng)式AI大(da)(da)模(mo)型在(zai)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)載(zai)語音助(zhu)手、場(chang)景化(hua)(hua)(hua)服務中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)深(shen)度集(ji)成(cheng)(cheng)(cheng)(cheng),某(mou)家專注于(yu)AI技(ji)(ji)術(shu)(shu)(shu)的(de)(de)(de)(de)(de)(de)(de)(de)科(ke)技(ji)(ji)公司(si)(si)(如已布局相(xiang)關(guan)(guan)**的(de)(de)(de)(de)(de)(de)(de)(de)百度、谷歌(ge)或一家初創(chuang)公司(si)(si))可(ke)能(neng)會(hui)對(dui)某(mou)家傳(chuan)(chuan)統(tong)(tong)(tong)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)巨頭發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi)**侵(qin)(qin)(qin)(qin)權(quan)(quan)(quan)(quan)(quan)訴(su)訟,指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)(qi)智(zhi)能(neng)座(zuo)艙系統(tong)(tong)(tong)中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)對(dui)話式AI、個性(xing)化(hua)(hua)(hua)推薦(jian)等(deng)(deng)(deng)功能(neng)侵(qin)(qin)(qin)(qin)犯(fan)了(le)(le)(le)其(qi)(qi)(qi)(qi)(qi)(qi)自(zi)(zi)然(ran)語言(yan)(yan)處理(NLP)和(he)(he)(he)(he)機器(qi)學(xue)(xue)習模(mo)型的(de)(de)(de)(de)(de)(de)(de)(de)**權(quan)(quan)(quan)(quan)(quan)。潛(qian)在(zai)影響(xiang)(xiang): 這(zhe)(zhe)類糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)將(jiang)把汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)IP戰(zhan)的(de)(de)(de)(de)(de)(de)(de)(de)戰(zhan)火從(cong)硬(ying)件(jian)(jian)(jian)(jian)、傳(chuan)(chuan)統(tong)(tong)(tong)軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)引(yin)向(xiang)(xiang)AI算(suan)法(fa)和(he)(he)(he)(he)數(shu)據處理層面,可(ke)能(neng)引(yin)發(fa)(fa)一系列關(guan)(guan)于(yu)AI生成(cheng)(cheng)(cheng)(cheng)內(nei)(nei)(nei)容版權(quan)(quan)(quan)(quan)(quan)和(he)(he)(he)(he)算(suan)法(fa)**有效性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)新(xin)法(fa)律挑(tiao)戰(zhan)。三、 軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)與(yu)(yu)(yu)用(yong)戶界面(UI)設計(ji)(ji)(ji)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)6:寶(bao)馬、奔馳等(deng)(deng)(deng) vs. **主(zhu)張(zhang)實(shi)(shi)體(ti)(PAE) (2020年(nian)(nian)(nian)(nian)(nian)至(zhi)今(jin))時(shi)(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)持(chi)續(xu)至(zhi)今(jin)爭議(yi)(yi)領域(yu)(yu): 車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)載(zai)軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)、通(tong)信(xin)協議(yi)(yi)等(deng)(deng)(deng)基礎**案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 多(duo)家汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)制(zhi)(zhi)(zhi)造(zao)商(shang)(shang),包括(kuo)寶(bao)馬、奔馳、大(da)(da)眾等(deng)(deng)(deng),持(chi)續(xu)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)**主(zhu)張(zhang)實(shi)(shi)體(ti)(Patent Assertion Entities,又(you)稱“**流氓”)的(de)(de)(de)(de)(de)(de)(de)(de)目標(biao)。這(zhe)(zhe)些(xie)(xie)PAE大(da)(da)量(liang)收(shou)購(gou)與(yu)(yu)(yu)3G/4G通(tong)信(xin)、導(dao)航(hang)(hang)軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)、車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)輛遠程(cheng)(cheng)信(xin)息處理等(deng)(deng)(deng)相(xiang)關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)基礎**,然(ran)后(hou)(hou)向(xiang)(xiang)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi)大(da)(da)規模(mo)**侵(qin)(qin)(qin)(qin)權(quan)(quan)(quan)(quan)(quan)訴(su)訟,尋(xun)求高額許(xu)可(ke)費或賠(pei)(pei)償(chang)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 這(zhe)(zhe)是(shi)一種持(chi)續(xu)性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)業(ye)(ye)(ye)(ye)現象(xiang)。車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)通(tong)常(chang)選擇達(da)成(cheng)(cheng)(cheng)(cheng)許(xu)可(ke)協議(yi)(yi)或進(jin)行(xing)(xing)法(fa)庭(ting)抗辯(bian)。例(li)如,2021年(nian)(nian)(nian)(nian)(nian),大(da)(da)陸集(ji)團(Continental)在(zai)美(mei)國(guo)(guo)(guo)*高法(fa)院(yuan)對(dui)Avanci等(deng)(deng)(deng)**池(chi)(chi)發(fa)(fa)起(qi)(qi)(qi)(qi)(qi)(qi)反(fan)壟斷訴(su)訟,試圖遏制(zhi)(zhi)(zhi)PAE的(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)為(wei)(wei)(wei),但(dan)未能(neng)成(cheng)(cheng)(cheng)(cheng)功。這(zhe)(zhe)已成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)整個汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)行(xing)(xing)業(ye)(ye)(ye)(ye)的(de)(de)(de)(de)(de)(de)(de)(de)“隱形成(cheng)(cheng)(cheng)(cheng)本”。來(lai)源(yuan)(yuan)(yuan):Juve Patent. (2021年(nian)(nian)(nian)(nian)(nian)多(duo)次(ci)報道(dao)). Avanci, Nokia lawsuits against Daimler and its suppliers.IAM Media. (2022年(nian)(nian)(nian)(nian)(nian)5月(yue)(yue)(yue)10日(ri)). The auto sector’s PAE problem is not going away.四、 設計(ji)(ji)(ji)與(yu)(yu)(yu)商(shang)(shang)標(biao)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)7:捷(jie)豹(bao)路(lu)虎(hu)(hu)(hu) vs. 江鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che) (2020年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)爭議(yi)(yi)領域(yu)(yu): 車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)型外(wai)觀(guan)設計(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 捷(jie)豹(bao)路(lu)虎(hu)(hu)(hu)(JLR)在(zai)中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)起(qi)(qi)(qi)(qi)(qi)(qi)訴(su)江鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che),指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)(qi)生產(chan)的(de)(de)(de)(de)(de)(de)(de)(de)陸風X7車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)型的(de)(de)(de)(de)(de)(de)(de)(de)外(wai)觀(guan)設計(ji)(ji)(ji)抄襲了(le)(le)(le)路(lu)虎(hu)(hu)(hu)攬(lan)勝極(ji)光(guang)(Range Rover Evoque)的(de)(de)(de)(de)(de)(de)(de)(de)獨特(te)設計(ji)(ji)(ji)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 北京市朝陽區(qu)人(ren)民(min)(min)法(fa)院(yuan)判(pan)決(jue)(jue)(jue)捷(jie)豹(bao)路(lu)虎(hu)(hu)(hu)勝訴(su)。法(fa)院(yuan)裁定江鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)必須立即停止(zhi)(zhi)陸風X7的(de)(de)(de)(de)(de)(de)(de)(de)所有銷(xiao)售、制(zhi)(zhi)(zhi)造(zao)和(he)(he)(he)(he)營(ying)(ying)銷(xiao)行(xing)(xing)為(wei)(wei)(wei),并(bing)向(xiang)(xiang)捷(jie)豹(bao)路(lu)虎(hu)(hu)(hu)支付(fu)賠(pei)(pei)償(chang)金(jin)。此案(an)(an)(an)(an)(an)(an)(an)是(shi)中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)法(fa)院(yuan)保護(hu)外(wai)資(zi)(zi)企(qi)業(ye)(ye)(ye)(ye)外(wai)觀(guan)設計(ji)(ji)(ji)產(chan)權(quan)(quan)(quan)(quan)(quan)的(de)(de)(de)(de)(de)(de)(de)(de)標(biao)志性(xing)案(an)(an)(an)(an)(an)(an)(an)例(li)。來(lai)源(yuan)(yuan)(yuan):北京市朝陽區(qu)人(ren)民(min)(min)法(fa)院(yuan) (2019) 京0105民(min)(min)初XX號民(min)(min)事判(pan)決(jue)(jue)(jue)書。BBC News. (2020年(nian)(nian)(nian)(nian)(nian)3月(yue)(yue)(yue)26日(ri)). Jaguar Land Rover wins Chinese copycat case.(預(yu)(yu)測) 案(an)(an)(an)(an)(an)(an)(an)例(li)8:Cybertruck設計(ji)(ji)(ji)元(yuan)(yuan)素爭議(yi)(yi) (2024-2025年(nian)(nian)(nian)(nian)(nian)預(yu)(yu)測)時(shi)(shi)間(jian): 2024年(nian)(nian)(nian)(nian)(nian)末-2025年(nian)(nian)(nian)(nian)(nian)(預(yu)(yu)測)爭議(yi)(yi)領域(yu)(yu): 標(biao)志性(xing)外(wai)觀(guan)設計(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)(qing)(qing)摘要(yao): 隨(sui)(sui)(sui)(sui)著(zhu)特(te)斯拉(la)Cybertruck的(de)(de)(de)(de)(de)(de)(de)(de)正(zheng)(zheng)(zheng)式交付(fu)和(he)(he)(he)(he)其(qi)(qi)(qi)(qi)(qi)(qi)**未來(lai)感的(de)(de)(de)(de)(de)(de)(de)(de)棱(leng)角(jiao)設計(ji)(ji)(ji)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)標(biao)志,其(qi)(qi)(qi)(qi)(qi)(qi)他車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)(尤(you)其(qi)(qi)(qi)(qi)(qi)(qi)是(shi)新(xin)興電(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)品牌或小(xiao)(xiao)眾制(zhi)(zhi)(zhi)造(zao)商(shang)(shang))若推出類似棱(leng)角(jiao)分明(ming)的(de)(de)(de)(de)(de)(de)(de)(de)皮卡(ka)或SUV車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)型,特(te)斯拉(la)可(ke)能(neng)會(hui)采取(qu)強硬(ying)的(de)(de)(de)(de)(de)(de)(de)(de)法(fa)律行(xing)(xing)動(dong)(dong)(dong)(dong)(dong),主(zhu)張(zhang)其(qi)(qi)(qi)(qi)(qi)(qi)獨特(te)的(de)(de)(de)(de)(de)(de)(de)(de)設計(ji)(ji)(ji)語言(yan)(yan)受保護(hu),從(cong)而引(yin)發(fa)(fa)新(xin)的(de)(de)(de)(de)(de)(de)(de)(de)設計(ji)(ji)(ji)**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。潛(qian)在(zai)影響(xiang)(xiang): 這(zhe)(zhe)將(jiang)測試汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)設計(ji)(ji)(ji)**在(zai)“非傳(chuan)(chuan)統(tong)(tong)(tong)”造(zao)型上(shang)的(de)(de)(de)(de)(de)(de)(de)(de)保護(hu)范(fan)圍(wei)。總結(jie)(jie)與(yu)(yu)(yu)趨勢分析(xi)主(zhu)戰(zhan)場(chang)轉移: 從(cong)傳(chuan)(chuan)統(tong)(tong)(tong)內(nei)(nei)(nei)燃機技(ji)(ji)術(shu)(shu)(shu)全(quan)面轉向(xiang)(xiang)電(dian)(dian)(dian)池(chi)(chi)、電(dian)(dian)(dian)驅(qu)、電(dian)(dian)(dian)控(kong)、智(zhi)能(neng)座(zuo)艙和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)(dong)(dong)駕(jia)(jia)(jia)駛軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)算(suan)法(fa)。爭議(yi)(yi)類型多(duo)樣化(hua)(hua)(hua): 從(cong)**侵(qin)(qin)(qin)(qin)權(quan)(quan)(quan)(quan)(quan)擴展(zhan)(zhan)(zhan)到商(shang)(shang)業(ye)(ye)(ye)(ye)秘(mi)密(mi)(mi)盜竊(qie)、軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)(jian)(jian)著(zhu)作權(quan)(quan)(quan)(quan)(quan)、UI/UX設計(ji)(ji)(ji)**以及標(biao)準必要(yao)**(SEP)許(xu)可(ke)費糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。主(zhu)體(ti)多(duo)元(yuan)(yuan)化(hua)(hua)(hua): 參與(yu)(yu)(yu)方(fang)不再僅是(shi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi),科(ke)技(ji)(ji)公司(si)(si)、零部(bu)(bu)件(jian)(jian)(jian)(jian)供應商(shang)(shang)、電(dian)(dian)(dian)池(chi)(chi)制(zhi)(zhi)(zhi)造(zao)商(shang)(shang)、**運營(ying)(ying)實(shi)(shi)體(ti)(NPEs/PAEs) 都深(shen)度參與(yu)(yu)(yu)其(qi)(qi)(qi)(qi)(qi)(qi)中(zhong)(zhong)(zhong)(zhong)(zhong)。地(di)域(yu)(yu)全(quan)球化(hua)(hua)(hua): 中(zhong)(zhong)(zhong)(zhong)(zhong)美(mei)歐成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)*主(zhu)要(yao)的(de)(de)(de)(de)(de)(de)(de)(de)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)戰(zhan)場(chang),尤(you)其(qi)(qi)(qi)(qi)(qi)(qi)是(shi)中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo),隨(sui)(sui)(sui)(sui)著(zhu)本土車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)企(qi)和(he)(he)(he)(he)技(ji)(ji)術(shu)(shu)(shu)公司(si)(si)的(de)(de)(de)(de)(de)(de)(de)(de)崛起(qi)(qi)(qi)(qi)(qi)(qi),其(qi)(qi)(qi)(qi)(qi)(qi)國(guo)(guo)(guo)內(nei)(nei)(nei)和(he)(he)(he)(he)國(guo)(guo)(guo)際(ji)IP訴(su)訟活動(dong)(dong)(dong)(dong)(dong)顯著(zhu)增(zeng)加。和(he)(he)(he)(he)解(jie)(jie)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)常(chang)態: 鑒于(yu)訴(su)訟成(cheng)(cheng)(cheng)(cheng)本高昂、技(ji)(ji)術(shu)(shu)(shu)復雜(za)性(xing)高且可(ke)能(neng)影響(xiang)(xiang)供應鏈,許(xu)多(duo)案(an)(an)(an)(an)(an)(an)(an)例(li)*終(zhong)以和(he)(he)(he)(he)解(jie)(jie)和(he)(he)(he)(he)交叉許(xu)可(ke)告終(zhong),但(dan)前(qian)提是(shi)雙方(fang)實(shi)(shi)力對(dui)等(deng)(deng)(deng)。說明(ming): 2025年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)案(an)(an)(an)(an)(an)(an)(an)例(li)基于(yu)當前(qian)行(xing)(xing)業(ye)(ye)(ye)(ye)動(dong)(dong)(dong)(dong)(dong)態和(he)(he)(he)(he)技(ji)(ji)術(shu)(shu)(shu)發(fa)(fa)展(zhan)(zhan)(zhan)趨勢進(jin)行(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)合理預(yu)(yu)測,旨在(zai)提供前(qian)瞻性(xing)視角(jiao)。實(shi)(shi)際(ji)發(fa)(fa)生的(de)(de)(de)(de)(de)(de)(de)(de)事件(jian)(jian)(jian)(jian)請(qing)(qing)以未來(lai)官方(fang)發(fa)(fa)布的(de)(de)(de)(de)(de)(de)(de)(de)信(xin)息為(wei)(wei)(wei)準。Ann Tel: +86 021-60778889- 808新(xin)能(neng)源(yuan)(yuan)(yuan)與(yu)(yu)(yu)智(zhi)能(neng)網聯(lian)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)(che)知(zhi)(zhi)識(shi)產(chan)權(quan)(quan)(quan)(quan)(quan)創(chuang)新(xin)峰會(hui)2025組委會(hui)2025 NEV & ICV IP Innovation Summit//zvuaz.cn/p/554988